Effective antiarrhythmic therapy improves survival for high-risk cardiac arrest survivors. Initial drug selection for these patients, particularly those without QT prolongation, often involves procainamide or quinidine.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: